Marksans Pharma Ltd
NSE:MARKSANS

Watchlist Manager
Marksans Pharma Ltd Logo
Marksans Pharma Ltd
NSE:MARKSANS
Watchlist
Price: 308.3 INR 0.85% Market Closed
Market Cap: 139.7B INR
Have any thoughts about
Marksans Pharma Ltd?
Write Note

Marksans Pharma Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Marksans Pharma Ltd
Gross Profit Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Marksans Pharma Ltd
NSE:MARKSANS
Gross Profit
â‚ą12.1B
CAGR 3-Years
16%
CAGR 5-Years
19%
CAGR 10-Years
16%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Gross Profit
â‚ą205B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Gross Profit
â‚ą177.7B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Gross Profit
â‚ą398.2B
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
8%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Gross Profit
â‚ą84.8B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
10%
M
Mankind Pharma Ltd
NSE:MANKIND
Gross Profit
â‚ą69.4B
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Marksans Pharma Ltd's Gross Profit?
Gross Profit
12.1B INR

Based on the financial report for Jun 30, 2024, Marksans Pharma Ltd's Gross Profit amounts to 12.1B INR.

What is Marksans Pharma Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
16%

Over the last year, the Gross Profit growth was 25%. The average annual Gross Profit growth rates for Marksans Pharma Ltd have been 16% over the past three years , 19% over the past five years , and 16% over the past ten years .

Back to Top